Cytokinetics Inc (NASDAQ:CYTK)

8.35
Delayed Data
As of Jun 19
 +0.10 / +1.21%
Today’s Change
6.75
Today|||52-Week Range
15.95
+2.45%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close8.25
Today’s open8.15
Day’s range8.00 - 8.35
Volume647,061
Average volume (3 months)357,038
Market cap$506.8M
Data as of 4:00pm ET, 06/19/2018

Growth & Valuation

Earnings growth (last year)-764.10%
Earnings growth (this year)+26.83%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-87.44%
P/E ratioNM
Price/Sales30.12
Price/Book4.59

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+0.05+0.26%
FLXNFlexion Therapeutics...+0.65+2.43%
ACRSAclaris Therapeutics...0.000.00%
AKBAAkebia Therapeutics ...+0.19+1.75%
Data as of 4:00pm ET, 06/19/2018

Financials

Next reporting dateAugust 1, 2018
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$13.4M
Annual profit (last year)-$127.8M
Net profit margin-955.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer &
Senior Vice President
Ching Jaw
Corporate headquarters
South San Francisco, California

Forecasts